Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 376,976	$ 19,782
Restricted cash	1,716	35
Prepaid expenses and other current assets	4,760	1,286
Total current assets	381,736	21,103
Restricted cash, non-current	1,716
Property, plant and equipment, net	6,507	1,461
Operating lease right-of-use assets	11,574
Other assets	454
Total assets	401,987	22,564
Current liabilities:
Accounts payable	2,453	630
Accrued compensation	2,689	466
Accrued research costs	633	1,764
Accrued expenses and other current liabilities	886	126
Current portion of operating lease liabilities	5,482
Series A redeemable convertible preferred stock tranche liability		29,062
Total current liabilities	12,143	32,048
Non-current operating lease liabilities	5,794
Other liabilities		316
Total liabilities	17,937	32,364
Commitments and contingencies (Note 6)
Stockholders’ equity (deficit):
Preferred stock, $0.00001 par value, 10,000,000 and zero shares authorized as of December 31, 2021 and 2020, respectively; and no shares issued and outstanding as of December 31, 2021 and 2020, respectively;
Common stock, $0.00001 par value, 300,000,000 and 80,000,000 shares authorized as of December 31, 2021 and 2020, respectively; 58,010,823 and 10,279,102 shares issued and outstanding as of December 31, 2021 and 2020, respectively	1
Additional paid-in-capital	525,400	5,183
Accumulated deficit	(141,351)	(70,591)
Total stockholders’ equity (deficit)	384,050	(65,408)
Total liabilities, redeemable convertible preferred stock, and stockholders’ equity (deficit)	$ 401,987	22,564
Series A Redeemable Convertible Preferred Stock
Current liabilities:
Convertible preferred stock		$ 55,608